Newsroom

Geistlich Announces Exciting Product Line Extension from Reoss: Yxoss CBR® Fully Protect

Geistlich Unveils Exciting Product Line Expansion: Introducing the SafeScraper TWIST VOLUMIZER

Celebrating Innovation and Legacy: Geistlich Pharma’s 11th Annual Philip J. Boyne Scholarship Award

Diego Gabathuler becomes the new CEO of Geistlich

Geistlich Pharma AG Executive Chairman, Dr. Andreas Geistlich, Honored with AAOMS Special Citation Award

TRUST STORIES: The new Geistlich movie – A Tale of an Intercontinental Challenge on Many Levels

[Video] MTF Tissue Processing

[Video] The MTF Biologics Donor Selection Process

[Video] Explore the MTF Biologics & Geistlich Partnership

Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration

Geistlich unveils vallos™ – a new demineralized allograft that sets the pace for regeneration

Geistlich Pharma North America, Inc. acquires Lynch Biologics, LLC, a biologics and tissue engineering company